SCHEMBL15823837

SCHEMBL15823837

COC=Cc1ccc2c(c1)oc(=O)n2CC/C=C/c1ccc(-c2ccccc2)c(NC(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PIK3CB P42338 1/20 0.37
▸ RECQL P46063 1/20 0.36
▸ TP53 P04637 2/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ RAB9A P51151 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MIF P14174 1/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15823835 1.00 PIK3CB (0.37) PIK3CBRECQLTP53SIGMAR1RAB9A
SCHEMBL15823838 1.00 PIK3CB (0.37) PIK3CBRECQLTP53SIGMAR1RAB9A
SCHEMBL15822599 0.92 TP53 (0.38) PIK3CBRECQLTP53SIGMAR1RAB9A
SCHEMBL15822602 0.92 TP53 (0.38) PIK3CBRECQLTP53SIGMAR1RAB9A
SCHEMBL15822603 0.92 TP53 (0.38) PIK3CBRECQLTP53SIGMAR1RAB9A
SCHEMBL15822931 0.90 PIK3CB (0.39) PIK3CBRECQLTP53SIGMAR1MAPT
SCHEMBL15822935 0.90 PIK3CB (0.39) PIK3CBRECQLTP53SIGMAR1MAPT
SCHEMBL15822472 0.86 PIK3CB (0.38) PIK3CBRECQLTP53SIGMAR1MAPT
SCHEMBL15822469 0.86 PIK3CB (0.38) PIK3CBRECQLTP53SIGMAR1MAPT
SCHEMBL15823566 0.85 PIK3CB (0.38) PIK3CBRECQLTP53SIGMAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 — — EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 — — WO disclosed
Send feedback